The antiphospholipid syndrome
Jean-Louis Pasquali1, Vincent Poindron, Anne-Sophie Korganow
1Clinical Immunology Department, Nouvel Hopital Civil, Hopitaux Universitaires de Strasbourg, Université de Strasbourg and INSERM, U737, 67091 Strasbourg, France. jean-louis.pasquali@chru-strasbourg.fr
Abstract:
The antiphospholipid syndrome is an acquired autoimmune syndrome characterized by arterial and/or venous thrombosis and/or pregnancy morbidity in association with the prolonged presence of serum autoantibodies, including the so-called lupus anticoagulant and anticardiolipin antibodies, which are mainly directed against complexes of proteins and anionic phospholipids.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

